Targeted proteomics via NULISAseq identifies blood‐detectable markers of disease progression in familial frontotemporal lobar degeneration

Overview of attention for article published in Alzheimer's & Dementia: the Journal of the Alzheimer's Association, December 2025

Altmetric Badge

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 869 followers.

RT @CanAkerman: Targeted proteomics via NULISAseq identifies blood-detectable markers of disease progression in familial frontotemporal lob…

Targeted proteomics via NULISAseq identifies blood-detectable markers of disease progression in familial frontotemporal lobar degeneration https://t.co/kXtFx5MNdX

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.